WEBINAR on
EXCESS MORTALITY & treatments
29 FEBRUARY 2024
Here is a video recording of our first Webinar of 2024 featuring world renowned Cardiologist Dr. Peter McCullough, who spoke about:
(1) the phenomena of excess deaths (that our government is afraid to talk about) and
(2) peer reviewed treatments to detox from spike protein for those who are still suffering from COVID.
INSURANCE COMPany data
Lincoln National, reported an increase in death benefits paid out under its group life insurance policies in 2021 compared to 2020.
The fifth largest life insurance company in the USA has confirmed it paid out $1.4billion in 2021 due to non-Covid related deaths among 18 to 64-year-olds. The amount represents a 176% increase since the Covid-19 injections were rolled out on the average payout for deaths over 2019 and 2020.
In an August 2022 poll among its more than 30,000 members worldwide, the SOA found that 85% of members thought excess mortality rates would continue to 2025. In August this year, the same poll found 79% believed excess mortality rates will continue through 2026.
Life Insurance News Oct 2023 - ‘Excess mortality’ continuing surge causes concerns
“The real concern for life insurers lies in preparing for an unexpected wave of death claims and the impact on their assets under management,” she said. “Do they have enough reserves to weather these outflows, given the excess deaths? It's not just about death or health. It is about the industry's ability and readiness to manage this monumental outflow.”
EXCESS MORTALITY DATA UK & germany
Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
The UK Office for National Statistics (ONS) has calculated that there were 7.2% or 44,255 more deaths registered in the UK in 2022 based on comparison with the five-year average (excluding 2020).1 This persisted into 2023 with 8.6% or 28,024 more deaths in the first 6 months of 2023.
The Lancet Dec 2023 - Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
This model finds that in the period from week ending 3rd June 2022 to 30th June 2023, excess deaths for all causes were relatively greatest for 50–64 year olds (15% higher than expected), compared with 11% higher for 25–49 and < 25 year olds, and about 9% higher for over 65 year old groups
Estimation of Excess Mortality in Germany During 2020-2022
The results show that the observed number of deaths in 2020 was close to the expected number with respect to the empirical standard deviation; approximately 4,000 excess deaths occurred. By contrast, in 2021, the observed number of deaths was two empirical standard deviations above the expected number and even more than four times the empirical standard deviation in 2022. In total, the number of excess deaths in the year 2021 is about 34,000 and in 2022 about 66,000 deaths, yielding a cumulated 100,000 excess deaths in both years.
EUROPEAN MORTALITY DATA
Cumulative European Excess mortality
These graphs were generated in week 2024-8 with data from 27 participating countries: Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Germany (Berlin), Germany (Hesse), Greece, Hungary, Ireland, Israel, Italy, Luxembourg, Malta, Netherlands, Portugal, Slovenia, Spain, Sweden, Switzerland, UK (England), UK (Northern Ireland), UK (Scotland), and UK (Wales).
European Excess mortality
In December 2023, excess mortality in the EU increased to 9.5 % above the baseline, compared with 8.5 % in November 2023.
In December 2023, excess mortality continued to vary across the EU. While Romania and Bulgaria recorded no excess deaths, Slovenia (21.3 %), Austria (20.7 %) and Estonia (20.0 %) had the highest rates among the EU countries.
deep dive into US data
SUMMARY
As of Week 6 of 2024, 3.96 years into the Covid-19 Pandemic and its aftermath, 1,625,842 excess deaths have been recorded to date.
​
Moreover, that disruption, lockdowns, iatrogenics, denial of treatment, along with our quod fieri final solution, have collectively served to kill the majority (namely 1,257,275 or 77.3%) of the US Citizens who died during the 206 weeks of the pandemic and its aftermath thus far.
As of Week 6 of 2024, 3.96 years into the Covid-19 Pandemic and its aftermath
As of February 10th 2024, there have been
-
706,036 Excess Non-Covid Natural Cause Deaths (primarily from the Covid Vaccine),
-
176,870 Excess Non-Natural Deaths (including 60,000 sudden cardiac deaths in casual drug users),
-
374,369 Excess Deaths from Malpractice and Denial of Treatment,
-
368,567 Excess Deaths from the SARS-CoV-2 virus (6.6 x annual influenza-pneumonia)
Chart 1 – Excess All Cause Mortality (USA) – without Pull Forward Effect
The beige line in the chart below shows the actual CDC Wonder deaths per week for the two years prior, as well as years-of and years-post the pandemic. The dark orange baseline is normalized from the years 2014-2019, representing a 1.4% annual growth in mortality for the US in terms of all causes. Without Pull Forward Effect (without PFE, or ‘nominal’) resides solidly at 7.5% excess.
Chart 2 – Excess Mortality Weekly Balance Sheet (USA)
Ages 0-54 Excess Cancer Mortality 24.9%
Ages 0-54 Sudden Cardiac Death Excess 44.4%
NOTE - a summary of all forms of excess mortality, with Pull Forward Effect (PFE) taken into account. PFE must be included, because each of the Big 12 ICD codes, ranked in terms of percentage excess in the chart above (beige boxes), contains pull forward effect.
Chart 3 – Excess Non-Covid Natural Cause Mortality (USA)
Excess Non-Natural Mortality (USA) stands at 8.5% or 4,645 persons per week over the last three weeks on average.
A total of 706,000 US Citizens have died primarily due to the major factor which has impacted this metric (the mRNA vaccine).
Chart 4 – Excess Non-Natural Mortality (USA)
Chart 4 – Excess Non-Natural Mortality (USA) – stands at 18.5% or 930 persons per week over the last seven weeks on average.
A total of 176,870 persons have died to date as a result of our policies selected and enforced during the early pandemic.
Chart 6 – Excess Cancer Mortality (USA)
5.4% (10-sigma) with Novel 2.4% CAGR
Chart 6 – Excess Cancer Mortality (USA) – stands at 5.4% or 665 persons per week over the last three weeks on average. More alarmingly however, is the novel compound annualized growth rate (CAGR) of 2.4%, a significant departure from the old growth rate of 0.23%
Chart 8 – Abnormal Clinical and Lab Findings Excess Mortality (USA)
Chart 8 – Abnormal Clinical and Lab Findings Excess Mortality (USA) – stands at 64% elevated versus historical standard. This represents the largest component (38.0%) of the Excess Non-Covid Natural Cause Mortality weekly total (shown in Charts 2 and 3 above) – deaths of unknown cause or abnormal findings in younger persons.
USA Sudden Cardiac Death Excess Mortality Ages 0-54 – 63.1% (29-sigma)
Chart 10 – Sudden Cardiac Death Mortality Ages 0-54 (USA) – as of week 34 of 2023 (must avoid the R99 and 999 periods as they are misleadingly high) stands at 63.1% elevated versus historic trend. This is an alarming 29-sigma excess.
USA All Non-Covid Natural Causes Excess Mortality Ages 0-24 – 25.5% (7-sigma)
Chart 12 – All Non-Covid Natural Causes Excess Mortality Ages 0-24 (USA) – stands at 25.5% elevated versus historic trend. This is a 7-sigma event. This is obfuscated (concealed) by the Covid-19 deaths during 2021 in older age groups; however, becomes clear when this age bracket is broken out separately.
treatment options for detoxing from spike protein
There are starting to appear in the medical literature treatments for Long COVID and vaccine injuries. Please note that clinical trials have not yet been completed.
Please refer to our disclaimer here
The empiric regimen can be continued for 3-12 months or more and be guided by clinical parameters:
-Nattokinase 2000 FU (100) mg orally twice a day without food
-Bromelain 500 mg orally once a day without food
-Curcumin 500 mg orally twice a day (nano, liposomal, or with piperine additive suggested)
No therapeutic claims can be made for this regimen because it has not been tested in large, prospective, double-blind, placebo controlled randomized trials. No such studies are planned or funded currently by federal or institutional sponsors. The main caveats are bleeding and allergic reactions. The regimen can be used in addition to antiplatelet and antithrombic agents, however, caution is advised with respect to monitoring bleeding risks.
the S1 segment accumulates in the body from SARS-CoV-2 infection and the full-length S1-S2 segment Spike is circulating and accumulating after genetic COVID-19 vaccination. Syndromes and diseases occurring as post-acute sequalae are caused by the Spike protein and the inflammation and damage it inflicts on the body.
​
The McCullough Protocol Base Spike Protein Detoxification is the only published method offering hope of elimination of Spike protein from the body as the root cause. It can be purchased here.